{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:35:08Z","timestamp":1767706508967,"version":"3.40.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/154\/46"],"award-info":[{"award-number":["RGP2\/154\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02574-4","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T06:11:40Z","timestamp":1746771100000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6248-8983","authenticated-orcid":false,"given":"Ayed A.","family":"Dera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6428-6278","authenticated-orcid":false,"given":"Majed","family":"Al Fayi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"2574_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.991330","volume":"10","author":"S Belkahla","year":"2022","unstructured":"Belkahla S, Nahvi I, Biswas S, Nahvi I, Ben Amor N. Advances and development of prostate cancer, treatment, and strategies: a systemic review. Front Cell Dev Biol. 2022;10: 991330.","journal-title":"Front Cell Dev Biol"},{"key":"2574_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a033688","volume":"9","author":"F Manna","year":"2019","unstructured":"Manna F, Karkampouna S, Zoni E, De Menna M, Hensel J, Thalmann GN, KruithofdeJulio M. Metastases in prostate cancer. Cold Spring Harbor Perspect Med. 2019;9: a033688.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2574_CR3","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3390\/ijms23031806","volume":"23","author":"I Luchian","year":"2022","unstructured":"Luchian I, Goriuc A, Sandu D, Covasa M. The role of matrix metalloproteinases (MMP-8, MMP-9, MMP-13) in periodontal and peri-implant pathological processes. Int J Mol Sci. 2022;23:1806.","journal-title":"Int J Mol Sci"},{"key":"2574_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","volume":"9","author":"P Wee","year":"2017","unstructured":"Wee P, Wang Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers. 2017;9:52.","journal-title":"Cancers"},{"key":"2574_CR5","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3390\/ijms18112420","volume":"18","author":"T Yamaoka","year":"2017","unstructured":"Yamaoka T, Ohba M, Ohmori T. Molecular-targeted therapies for epidermal growth factor receptor and its resistance mechanisms. Int J Mol Sci. 2017;18:2420.","journal-title":"Int J Mol Sci"},{"key":"2574_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5732\/cjc.010.10542","volume":"30","author":"J Wykosky","year":"2011","unstructured":"Wykosky J, Fenton T, Furnari F, Cavenee WK. Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations. Chin J Cancer. 2011;30:5\u201312.","journal-title":"Chin J Cancer"},{"key":"2574_CR7","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-14-3380","volume":"75","author":"YS Chang","year":"2015","unstructured":"Chang YS, Chen WY, Yin JJ, Sheppard-Tillman H, Huang J, Liu YN. EGF receptor promotes prostate cancer bone metastasis by downregulating miR-1 and activating TWIST1. Can Res. 2015;75:3077\u201386.","journal-title":"Can Res"},{"key":"2574_CR8","doi-asserted-by":"publisher","first-page":"1260491","DOI":"10.3389\/fendo.2023.1260491","volume":"14","author":"H Lan","year":"2023","unstructured":"Lan H, Wu B, Jin K, Chen Y. Beyond boundaries: unraveling innovative approaches to combat bone-metastatic cancers. Front Endocrinol. 2023;14:1260491.","journal-title":"Front Endocrinol"},{"key":"2574_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","volume":"3","author":"A Gandalovi\u010dov\u00e1","year":"2017","unstructured":"Gandalovi\u010dov\u00e1 A, Rosel D, Fernandes M, Vesel\u00fd P, Heneberg P, \u010cerm\u00e1k V, Petru\u017eelka L, Kumar S, Sanz-Moreno V, Br\u00e1bek J. Migrastatics-anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer. 2017;3:391\u2013406.","journal-title":"Trends Cancer"},{"key":"2574_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/pros.24090","volume":"81","author":"R Imamura","year":"2021","unstructured":"Imamura R, Kitagawa S, Kubo T, Irie A, Kariu T, Yoneda M, Kamba T, Imamura T. Prostate cancer C5a receptor expression and augmentation of cancer cell proliferation, invasion, and PD-L1 expression by C5a. Prostate. 2021;81:147\u201356.","journal-title":"Prostate"},{"key":"2574_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12094-022-02956-y","volume":"25","author":"D Xu","year":"2023","unstructured":"Xu D, Li M, Ran L, Li X, Sun X, Yin T. C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt\/\u03b2-catenin pathway. Clin Transl Oncol. 2023;25:440\u20136.","journal-title":"Clin Transl Oncol"},{"key":"2574_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1586\/1744666X.2015.983081","volume":"11","author":"VR Darling","year":"2015","unstructured":"Darling VR, Hauke RJ, Tarantolo S, Agrawal DK. Immunological effects and therapeutic role of C5a in cancer. Expert Rev Clin Immunol. 2015;11:255\u201363.","journal-title":"Expert Rev Clin Immunol"},{"key":"2574_CR13","first-page":"913","volume":"17","author":"M Yoneda","year":"2019","unstructured":"Yoneda M, Imamura R, Nitta H, Taniguchi K, Saito F, Kikuchi K, Ogi H, Tanaka T, Katabuchi H, Nakayama H, Imamura T. Enhancement of cancer invasion and growth via the C5a\u2013C5a receptor system: implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion. Oncol Lett. 2019;17:913\u201320.","journal-title":"Oncol Lett"},{"issue":"Suppl","key":"2574_CR14","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1007\/s002800051097","volume":"43","author":"DE Kleiner","year":"1999","unstructured":"Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol. 1999;43(Suppl):S42-51.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2574_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/sj.bjc.6605569","volume":"102","author":"S Escaff","year":"2010","unstructured":"Escaff S, Fern\u00e1ndez JM, Gonz\u00e1lez LO, Su\u00e1rez A, Gonz\u00e1lez-Reyes S, Gonz\u00e1lez JM, Vizoso FJ. Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer. 2010;102:922\u20139.","journal-title":"Br J Cancer"},{"key":"2574_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2007.02.006","volume":"254","author":"PR Dutta","year":"2007","unstructured":"Dutta PR, Maity A. Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett. 2007;254:165\u201377.","journal-title":"Cancer Lett"},{"key":"2574_CR17","doi-asserted-by":"publisher","first-page":"7060","DOI":"10.1158\/1078-0432.CCR-08-1455","volume":"14","author":"DB Costa","year":"2008","unstructured":"Costa DB, Nguyen KS, Cho BC, Sequist LV, Jackman DM, Riely GJ, Yeap BY, Halmos B, Kim JH, J\u00e4nne PA, Huberman MS, Pao W, Tenen DG, Kobayashi S. Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib. Clin Can Res. 2008;14:7060\u20137.","journal-title":"Clin Can Res"},{"key":"2574_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nrc2947","volume":"10","author":"W Pao","year":"2010","unstructured":"Pao W, Chmielecki J. Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer. 2010;10:760\u201374.","journal-title":"Nat Rev Cancer"},{"key":"2574_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymthe.2023.12.010","volume":"32","author":"X Luan","year":"2024","unstructured":"Luan X, Lei T, Fang J, Liu X, Fu H, Li Y, Chu W, Jiang P, Tong C, Qi H, Fu Y. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8(+) T cell activity. Mol Ther. 2024;32:469\u201389.","journal-title":"Mol Ther"},{"key":"2574_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/bab.2716","author":"MA Alghamdi","year":"2025","unstructured":"Alghamdi MA, Deshpande H. Dual targeting of MEK1 and Akt kinase identified SBL-027 as a promising lead candidate to control cell proliferations in gastric cancer. Biotechnol Appl Biochem. 2025. https:\/\/doi.org\/10.1002\/bab.2716.","journal-title":"Biotechnol Appl Biochem"},{"key":"2574_CR21","first-page":"2771","volume":"43","author":"M Al Shahrani","year":"2023","unstructured":"Al Shahrani M, AboHassan M, Gahtani R, Alshahrani MY, Suliman M, Ahmad I, Saeed M. High-throughput screening and in\u00a0vitro evaluation of CSB-0914; a novel small molecule NF-\u03baB inhibitor attenuating inflammatory responses through NF-\u03baB, Nrf2 and HO-1 cross-talk. J Biomol Struct Dyn. 2023;43:2771.","journal-title":"J Biomol Struct Dyn"},{"key":"2574_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/BJ20121513","volume":"448","author":"JH Park","year":"2012","unstructured":"Park JH, Liu Y, Lemmon MA, Radhakrishnan R. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain. Biochem J. 2012;448:417\u201323.","journal-title":"Biochem J"},{"key":"2574_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41422-023-00779-2","volume":"33","author":"Y Feng","year":"2023","unstructured":"Feng Y, Zhao C, Deng Y, Wang H, Ma L, Liu S, Tian X, Wang B, Bin Y, Chen P, Yan W, Fu P, Shao Z. Mechanism of activation and biased signaling in complement receptor C5aR1. Cell Res. 2023;33:312\u201324.","journal-title":"Cell Res"},{"key":"2574_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/5924799","volume":"2024","author":"PD Utami","year":"2024","unstructured":"Utami PD, Setianingsih H, Sari DRT. In silico approach triterpene glycoside of H. atra targeting orotidine 5-monophosphate decarboxylase protein (PfOMPDC) in P. falciparum infection mechanism. BioMed Res Int. 2024;2024: 5924799.","journal-title":"BioMed Res Int"},{"key":"2574_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108135","volume":"112","author":"D Rababi","year":"2024","unstructured":"Rababi D, Nag A. A top-down approach for studying the in-silico effect of the novel phytocompound tribulusamide B on the inhibition of Nipah virus transmission through targeting fusion glycoprotein and matrix protein. Comput Biol Chem. 2024;112: 108135.","journal-title":"Comput Biol Chem"},{"key":"2574_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14178","volume":"46","author":"M Abohassan","year":"2022","unstructured":"Abohassan M, Al Shahrani M, Ahmad I, Abullais SS, Srivastava S, Rajagopalan P. GC\/MS characterization and computational kinome-wide screening of pomegranate fruit extract identifies key phytochemicals interacting to CDK kinases implicated in acute myeloid leukemia cells. J Food Biochem. 2022;46: e14178.","journal-title":"J Food Biochem"},{"issue":"3","key":"2574_CR27","doi-asserted-by":"publisher","first-page":"675","DOI":"10.32604\/or.2024.056256","volume":"33","author":"M Abohassan","year":"2025","unstructured":"Abohassan M, Shahrani MMA, Alouda SK, Rajagopalan P. Dibenzo [a, c] phenazin-11-yl(phenyl) methanone (SBLJ23), a novel selective inhibitor targeting JAK2V617F mutation in myeloproliferative neoplasms. Oncol Res. 2025;33(3):675.","journal-title":"Oncol Res"},{"key":"2574_CR28","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1158\/0008-5472.CAN-11-0213","volume":"71","author":"M Wang","year":"2011","unstructured":"Wang M, Morsbach F, Sander D, Gheorghiu L, Nanda A, Benes C, Kriegs M, Krause M, Dikomey E, Baumann M, Dahm-Daphi J, Settleman J, Willers H. EGF receptor inhibition radiosensitizes NSCLC cells by inducing senescence in cells sustaining DNA double-strand breaks. Can Res. 2011;71:6261\u20139.","journal-title":"Can Res"},{"key":"2574_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1517\/14712590902735795","volume":"13","author":"EA Hopper-Borge","year":"2009","unstructured":"Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opin Ther Targets. 2009;13:339\u201362.","journal-title":"Expert Opin Ther Targets"},{"key":"2574_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2017.10.003","volume":"412","author":"J Chen","year":"2018","unstructured":"Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, Wu YZ. Complement C5a\/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Cancer Lett. 2018;412:30\u20136.","journal-title":"Cancer Lett"},{"issue":"Suppl","key":"2574_CR31","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","volume":"35","author":"MA Feitelson","year":"2015","unstructured":"Feitelson MA, Arzumanyan A, Kulathinal RJ, Blain SW, Holcombe RF, Mahajna J, Marino M, Martinez-Chantar ML, Nawroth R, Sanchez-Garcia I, Sharma D, Saxena NK, Singh N, Vlachostergios PJ, Guo S, Honoki K, Fujii H, Georgakilas AG, Bilsland A, Amedei A, Niccolai E, Amin A, Ashraf SS, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Keith WN, Nowsheen S. Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35(Suppl):S25-s54.","journal-title":"Semin Cancer Biol"},{"key":"2574_CR32","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41392-024-01955-5","volume":"9","author":"Z Liu","year":"2024","unstructured":"Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, Luo P, Cheng Q, Xu H, Han X. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. Signal Transduct Target Ther. 2024;9:270.","journal-title":"Signal Transduct Target Ther"},{"key":"2574_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/antib9040057","volume":"9","author":"M Revel","year":"2020","unstructured":"Revel M, Daugan MV, Saut\u00e9s-Fridman C, Fridman WH, Roumenina LT. Complement system: promoter or suppressor of cancer progression? Antibodies. 2020;9:57.","journal-title":"Antibodies"},{"key":"2574_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00011-010-0178-4","volume":"59","author":"R Kurihara","year":"2010","unstructured":"Kurihara R, Yamaoka K, Sawamukai N, Shimajiri S, Oshita K, Yukawa S, Tokunaga M, Iwata S, Saito K, Chiba K, Tanaka Y. C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflamm Res. 2010;59:659\u201366.","journal-title":"Inflamm Res"},{"key":"2574_CR35","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-07-5154","volume":"68","author":"A Guti\u00e9rrez-Fern\u00e1ndez","year":"2008","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez A, Fueyo A, Folgueras AR, Garabaya C, Pennington CJ, Pilgrim S, Edwards DR, Holliday DL, Jones JL, Span PN, Sweep FC, Puente XS, L\u00f3pez-Ot\u00edn C. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Can Res. 2008;68:2755\u201363.","journal-title":"Can Res"},{"key":"2574_CR36","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1021\/jm400822z","volume":"56","author":"RA Ward","year":"2013","unstructured":"Ward RA, Anderton MJ, Ashton S, Bethel PA, Box M, Butterworth S, Colclough N, Chorley CG, Chuaqui C, Cross DA, Dakin LA, Debreczeni J, Eberlein C, Finlay MR, Hill GB, Grist M, Klinowska TC, Lane C, Martin S, Orme JP, Smith P, Wang F, Waring MJ. Structure- and reactivity-based development of covalent inhibitors of the activating and gatekeeper mutant forms of the epidermal growth factor receptor (EGFR). J Med Chem. 2013;56:7025\u201348.","journal-title":"J Med Chem"},{"key":"2574_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054136","volume":"8","author":"JM Sanders","year":"2013","unstructured":"Sanders JM, Wampole ME, Thakur ML, Wickstrom E. Molecular determinants of epidermal growth factor binding: a molecular dynamics study. PLoS ONE. 2013;8: e54136.","journal-title":"PLoS ONE"},{"key":"2574_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fchem.2020.00726","volume":"8","author":"F Wu","year":"2020","unstructured":"Wu F, Zhou Y, Li L, Shen X, Chen G, Wang X, Liang X, Tan M, Huang Z. Computational approaches in preclinical studies on drug discovery and development. Front Chem. 2020;8:726.","journal-title":"Front Chem"},{"key":"2574_CR39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth SA, Dror RO. Molecular dynamics simulation for all. Neuron. 2018;99:1129\u201343.","journal-title":"Neuron"},{"key":"2574_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.32604\/or.2024.055677","volume":"33","author":"HM Otifi","year":"2025","unstructured":"Otifi HM. SBL-JP-0004: a promising dual inhibitor of JAK2 and PI3KCD against gastric cancer. Oncol Res. 2025;33:235\u201343.","journal-title":"Oncol Res"},{"key":"2574_CR41","doi-asserted-by":"publisher","first-page":"7576","DOI":"10.1016\/j.bmc.2007.09.010","volume":"15","author":"AK Ghosh","year":"2007","unstructured":"Ghosh AK, Dawson ZL, Mitsuya H. Darunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIV. Bioorg Med Chem. 2007;15:7576\u201380.","journal-title":"Bioorg Med Chem"},{"key":"2574_CR42","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/molecules27030819","volume":"27","author":"T Amelia","year":"2022","unstructured":"Amelia T, Kartasasmita RE, Ohwada T, Tjahjono DH. Structural insight and development of EGFR tyrosine kinase inhibitors. Molecules. 2022;27:819.","journal-title":"Molecules"},{"key":"2574_CR43","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/sj.bjc.6604278","volume":"98","author":"GE Konecny","year":"2008","unstructured":"Konecny GE, Venkatesan N, Yang G, Dering J, Ginther C, Finn R, Rahmeh M, Fejzo MS, Toft D, Jiang SW, Slamon DJ, Podratz KC. Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells. Br J Cancer. 2008;98:1076\u201384.","journal-title":"Br J Cancer"},{"key":"2574_CR44","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/acsomega.9b03735","volume":"5","author":"V Kumar","year":"2020","unstructured":"Kumar V, Lee JD, Clark RJ, Noakes PG, Taylor SM, Woodruff TM. Preclinical pharmacokinetics of complement C5a receptor antagonists PMX53 and PMX205 in mice. ACS Omega. 2020;5:2345\u201354.","journal-title":"ACS Omega"},{"key":"2574_CR45","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.3390\/ijms20184506","volume":"20","author":"K Juurikka","year":"2019","unstructured":"Juurikka K, Butler GS, Salo T, Nyberg P, \u00c5str\u00f6m P. The role of MMP8 in cancer: a systematic review. Int J Mol Sci. 2019;20:4506.","journal-title":"Int J Mol Sci"},{"key":"2574_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3892\/etm.2022.11420","volume":"24","author":"S Luo","year":"2022","unstructured":"Luo S, Xu H, Gong X, Shen J, Chen X, Wu Z. The complement C3a\u2013C3aR and C5a\u2013C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-\u03baB signaling. Exp Ther Med. 2022;24:493.","journal-title":"Exp Ther Med"},{"key":"2574_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.18632\/aging.100296","volume":"3","author":"LS Steelman","year":"2011","unstructured":"Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F, Mazzarino MC, Donia M, Fagone P, Malaponte G, Nicoletti F, Libra M, Milella M, Tafuri A, Bonati A, B\u00e4secke J, Cocco L, Evangelisti C, Martelli AM, Montalto G, Cervello M, McCubrey JA. Roles of the Raf\/MEK\/ERK and PI3K\/PTEN\/Akt\/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging. 2011;3:192\u2013222.","journal-title":"Aging"},{"key":"2574_CR48","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.201703-0660OC","volume":"197","author":"D Ajona","year":"2018","unstructured":"Ajona D, Zandueta C, Corrales L, Moreno H, Pajares MJ, Ortiz-Espinosa S, Mart\u00ednez-Terroba E, Perurena N, de Miguel FJ, Jantus-Lewintre E, Camps C, Vicent S, Agorreta J, Montuenga LM, Pio R, Lecanda F. Blockade of the complement C5a\/C5aR1 axis impairs lung cancer bone metastasis by CXCL16-mediated effects. Am J Respir Crit Care Med. 2018;197:1164\u201376.","journal-title":"Am J Respir Crit Care Med"},{"key":"2574_CR49","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.3390\/cancers14143337","volume":"14","author":"A Koulouris","year":"2022","unstructured":"Koulouris A, Tsagkaris C, Corriero AC, Metro G, Mountzios G. Resistance to TKIs in EGFR-mutated non-small cell lung cancer: from mechanisms to new therapeutic strategies. Cancers. 2022;14:3337.","journal-title":"Cancers"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02574-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02574-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T07:04:04Z","timestamp":1746774244000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02574-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2574"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02574-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, consent to participate, human and animal rights"}},{"value":"The authors give their consent to the journal for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"710"}}